Clinical Trial Update: Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of gefitinib for recurrent/metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED